Series A financing to support Modis' development of MT-1621 for thymidine kinase 2 deficiency Oct. 4, 2018
Phase III IMPLANT 2 results show nolasiban improves live birth rate in women undergoing IVF Oct. 3, 2018
Phase III studies of Lilly's Ultra Rapid Lispro in diabetes meet primary efficacy endpoint Oct. 3, 2018
First clinical data presented for nifedipine in patients with hyperinsulinemic hypoglycemia Oct. 3, 2018
Salk awarded CIRM grant to support development of immune-tolerant human islet-like organoids Oct. 2, 2018
RSS